Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00060606 · ClinicalTrials.gov registry record · NA
Management of Myelomeningocele Study (MOMS)
A NA study, sponsored by The George Washington University Biostatistics Center.
- Completed
- Registry status
- NA
- Development phase
- 183
- Enrollment target
NCT00060606: Completed NA study, sponsored by The George Washington University Biostatistics Center.
NCT00060606 is a NA study that has completed, run by The George Washington University Biostatistics Center. The registered enrollment target is 183 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00060606, a NA study, has completed, sponsored by The George Washington University Biostatistics Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 183 participants
- Enrollment target
Study Summary
Spina bifida (myelomeningocele) is a complex birth defect in which a portion of the spinal cord is not fully developed. The overlying bones and skin are incompletely formed and the underdeveloped area of the spinal cord is exposed on the surface of the back. Spina bifida defects are closed soon after birth to prevent further damage to the spinal cord and nerves. The Management of Myelomeningocele Study (MOMS) is a research study comparing two approaches to the treatment of babies with spina bifida: surgery before birth (prenatal surgery) and the standard closure, surgery after birth (postnatal surgery).
Interventions
- PROCEDURE Prenatal Myelomeningocele Repair Surgery
- PROCEDURE Postnatal Myelomeningocele Repair Surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 183 participants |
| Start Date | 2003-02 |
| Est. Completion | 2017-06 |
| Phase | NA |
What the finished NCT00060606 record still lists
NCT00060606 is an interventional study that assigns participants to a tested intervention. The registered 183 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 2 interventions - of which Prenatal Myelomeningocele Repair Surgery is the first listed.
NCT00060606 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00060606 about?
NCT00060606 is a clinical study titled "Management of Myelomeningocele Study (MOMS)". Spina bifida (myelomeningocele) is a complex birth defect in which a portion of the spinal cord is not fully developed. The overlying bones and skin are incompletely formed and the underdeveloped area of the spinal cord is exposed on the surface of the back. Spina bifida defects are closed soon afte...
What is the current status of trial NCT00060606?
This trial is currently completed. It is a NA study. The enrollment target is 183 participants. The study started on 2003-02. Estimated completion is 2017-06.
What interventions are being tested in trial NCT00060606?
The interventions under investigation include: Prenatal Myelomeningocele Repair Surgery (PROCEDURE), Postnatal Myelomeningocele Repair Surgery (PROCEDURE).
Who is sponsoring clinical trial NCT00060606?
This trial is sponsored by The George Washington University Biostatistics Center, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00060606's enrollment target sits among peer trials
183 584th of 2000 higher than 1,417 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03859297 · 183 participants · NA
Mechanisms of Rumination Change in Adolescent Depression
- NCT04270591 · 183 participants · Phase 1
Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer
- NCT06764615 · 183 participants · Phase 2
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
- NCT06872684 · 183 participants · NA
Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia